Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001793
Filing Date
2024-11-07
Accepted
2024-11-07 16:10:41
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240930x10q.htm   iXBRL 10-Q 1922493
2 EX-10.36 tmb-20240930xex10d36.htm EX-10.36 65663
3 EX-31.1 tmb-20240930xex31d1.htm EX-31.1 10565
4 EX-31.2 tmb-20240930xex31d2.htm EX-31.2 11427
5 EX-32.1 tmb-20240930xex32d1.htm EX-32.1 5473
  Complete submission text file 0001410578-24-001793.txt   8418391

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240930.xsd EX-101.SCH 70050
7 EX-101.CAL tmb-20240930_cal.xml EX-101.CAL 57591
8 EX-101.DEF tmb-20240930_def.xml EX-101.DEF 237915
9 EX-101.LAB tmb-20240930_lab.xml EX-101.LAB 471940
10 EX-101.PRE tmb-20240930_pre.xml EX-101.PRE 411802
81 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240930x10q_htm.xml XML 1360374
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55066 | Film No.: 241435744
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)